Lancer Containe. (LANCER)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at P/B of 0.71, a 29% discount to book value of ₹15.36
• ROCE is slightly positive at 0.51%, indicating some residual operating return
• Market cap of ₹246 crore is small, allowing potential for high growth if business turns
• 52-week range ₹7.16–₹12.28 shows price recovery from lows, suggesting some buying interest

Concerns

• Sales growth of -73.33% and profit growth of -282.11% show severe business deterioration
• Latest quarter net loss of ₹7 crore on sales of ₹54 crore; ROE negative at -0.73%
• Piotroski F-Score of 3/9 indicates poor financial health and weak operating efficiency
• Promoter holding at 31.66% is low for an Indian small-cap, raising governance alignment questions; no dividend yield

AI Analysis

At ₹10.96, Lancer Container is trading at a 29% discount to its stated book value of ₹15.36. That looks like a classic margin of safety, but Benjamin Graham would remind me that a rupee of book value is only worth what it can earn. The picture here is troubling. Sales have collapsed by 73%, and profit growth has turned deeply negative at -282%. The latest quarter shows ₹54 crore in sales but a net loss of ₹7 crore. ROE is -0.73%, so the business is destroying shareholder value, not creating it. ROCE is barely positive at 0.51%, indicating negligible operating efficiency. The Piotroski F-Score of 3 out of 9 reinforces the weak fundamentals — this is a business under financial stress, not a quiet compounding machine. Promoter holding of 31.66% is moderate but not a strong vote of confidence, and there is no dividend to reward patient holders. The low price-to-book ratio could signal an asset play, but I cannot assess the quality of those assets from these numbers alone. Debt/Equity is not available, which adds uncertainty. In India, small-cap logistics companies can face severe cyclical pressures, and this may be a troubled turnaround rather than a cheap bargain. As Graham said, price is what you pay, value is what you get. Here, I see a deteriorating business whose book value may not be fully recoverable. I would wait for evidence of sales stabilization, a path to profitability, and better capital allocation before considering an investment. For now, this is a pass — the discount may be justified by the damage.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer